Source Details

View detailed information about this source submission and its extracted claims.

Back to Sources

https://reason.com/2025/11/12/the-perils-of-viewing-psilocybin-strictly-as-a-psy...

Completed

18 claims 🔥

5 months ago

https://reason.com/2025/11/12/the-perils-of-viewing-psilocybin-strictly-as-a-psychiatric-medication

Source Information

Complete details about this source submission.

URL: https://reason.com/2025/11/12/the-perils-of-viewing-psilocybin-strictly-as-a-psychiatric-medication
Overall Status: Completed
Submitted By: Donato V. Pompo
Submission Date: November 14, 2025 at 12:17 AM
Metadata: { "source_type": "extension", "content_hash": "c03f885817bf536fca752c9c1602b9d9a82c4a757576c055a53b2e71cacbfa50", "submitted_via": "chrome_extension", "extension_version": "1.0.18", "original_url": "https:\/\/reason.com\/2025\/11\/12\/the-perils-of-viewing-psilocybin-strictly-as-a-psychiatric-medication\/?utm_source=Reason+Magazine&utm_campaign=84a5637b8f-reason_brand%7Cnew_at_reason%7C2025_11_13&utm_medium=email&utm_term=0_31d7ef7f57-84a5637b8f-589886052" }
Database ID: 4099
UUID: a059e470-04a6-427f-b799-cc28d89a406f
Submitted By User ID: 7
Created At: November 14, 2025 at 12:17 AM
Updated At: November 14, 2025 at 12:17 AM
Original Content: <html lang="en-US"><head><script type="text/javascript" async="" src="https://analytics.tiktok.com/i18n/pixel/static/identify_c4432507.js"></script><script type="text/javascript" async="" src="https://analytics.tiktok.com/i18n/pixel/static/main.MWYyNDJlNWM5MA.js" data-id="CCM8GMBC77U8584I7380"></script><script src="https://rules.quantcount.com/rules-p-UeXruRVtZz7w6.js" async=""></script><script src="https://cdn.hadronid.net/hadron.js?url=https%3A%2F%2Freason.com%2F2025%2F11%2F12%2Fthe-perils-of-viewing-psilocybin-strictly-as-a-psychiatric-medication%2F%3Futm_source%3DReason%2BMagazine%26utm_campaign%3D84a5637b8f-reason_brand%257Cnew_at_reason%257C2025_11_13%26utm_medium%3Demail%26utm_term%3D0_31d7ef7f57-84a5637b8f-589886052&ref=&_it=freestar&partner_id=474&ha=_hadron"></script><script src="https://btloader.com/tag?o=5714937848528896&upapi=true"></script><meta http-equiv="origin-trial" content="A7vZI3v+Gz7JfuRolKNM4Aff6zaGuT7X0mf3wtoZTnKv6497cVMnhy03KDqX7kBz/q/iidW7s...

Processing Status Details

Detailed status of each processing step.

Pipeline Status: Completed
AI Extraction Status: Pending

Re-evaluate with Updated AI

Re-process this source with the latest AI models and improved claim extraction algorithms. This will update the AI analysis and extract new claims without re-scraping the content.

Claims from this Source (18)

All claims extracted from this source document.

The Scottsdale Research Institute (SRI) grows psilocybin mushrooms in Arizona with permission from the Drug Enforcement Administration.
0.900

🆔 e89f7a58-d6eb-4581-a713-97dda45c6461

Simplified: SRI grows psilocybin mushrooms in Arizona with DEA permission.
Late last month, the organization announced that it will use those mushrooms in a state-funded study testing their effectiveness in treating post-traumatic stress disorder (PTSD).
0.900

🆔 be0db057-5413-486b-8110-07293106cabc

Simplified: SRI will use mushrooms in state-funded PTSD study.
That project, which the Food and Drug Administration (FDA) has greenlit, exemplifies a renaissance of research investigating the psychotherapeutic potential of a drug that has been federally prohibite...
0.800

🆔 0f6ba0a7-8b8b-4a93-865a-4f506a3ffddf

Simplified: FDA approved project shows renewed research into psilocybin.
The SRI study, which will include 24 veterans, firefighters, and police officers diagnosed with PTSD, is the first to use whole mushrooms rather than synthetic psilocybin.
0.900

🆔 1b9e66bd-3c38-4690-bb62-030de6c6a800

Simplified: SRI's PTSD study uses whole mushrooms, not synthetic psilocybin.
SRI President Sue Sisley says she aims to explore the possibility that other components of psilocybin mushrooms contribute to their effects.
0.900

👤 Sue Sisley 🆔 cf325eb0-7635-4644-ae3c-b12c1765d468

Simplified: Sue Sisley wants to study other psilocybin components.
November 13th, 2025 – Morning
1.000

🆔 6bb75de1-c3b4-45f6-9b34-889569b6c13a

Simplified: News bulletin on November 13, 2025.
In 2018, the FDA recognized psilocybin as a "breakthrough therapy" for "treatment-resistant depression," a designation that was supposed to facilitate regulatory approval.
0.900

🆔 cf05c324-5853-41fd-857e-0309476ceee3

Simplified: FDA designated psilocybin a 'breakthrough therapy' in 2018.
Subsequent studies have reinforced the case for psilocybin-assisted psychotherapy as a treatment for depression and cancer-related anxiety, and it also looks promising as a PTSD treatment.
0.700

🆔 508f445a-434e-4914-b45a-3fab811a2595

Simplified: Studies support psilocybin for depression, anxiety, and PTSD.
Five years ago, Oregon voters took a different approach, approving a ballot initiative that authorized state-licensed "psilocybin service centers" where adults 21 or older can use the drug under the s...
0.900

🆔 c9b06886-4039-413a-9683-24a88f869027

Simplified: Oregon voters approved psilocybin service centers five years ago.
Colorado voters went further two years later, passing an initiative that not only authorized "healing centers" but decriminalized the noncommercial production, possession, and transfer of psilocybin a...
0.900

🆔 55f245de-726d-48d6-9725-bd331ccce23a

Simplified: Colorado decriminalized psilocybin and other psychedelics.
a Denver ballot initiative in 2019, that discouraged the arrest and prosecution of psychedelic users.
0.900

🆔 7731ddfb-4579-4958-9bcc-a2af743a0fd1

Simplified: Denver discouraged arresting psychedelic users in 2019.
In a 2023 RAND Corporation survey of people who had used psilocybin in the last year, 49 percent described their goal as "improved mental health," a category that includes but extends beyond individua...
0.800

🆔 30fc585f-2b3b-43a9-a09d-4a73912df5b5

Simplified: 49% used psilocybin for mental health in a 2023 RAND survey.
Other common responses included "personal development" (45 percent), "curiosity" (43 percent), "spiritual growth" (41 percent), and "cognitive development" (41 percent).
0.800

🆔 ca60b05a-9204-496f-82c9-38b1ca8142d4

Simplified: Other psilocybin use motives: personal development, curiosity, etc.
Fifty-nine percent of respondents said they used psilocybin for "fun," e.g., "for a sense of joy, pleasure, or play, including at a party or other social gathering."
0.800

🆔 d57ccc94-c4be-45ca-91e3-6c28e763f23c

Simplified: 59% used psilocybin for fun.
In Texas, where I live, possessing less than a gram of the wrong fungus is punishable by up to two years in jail, while one to four grams can get you up to 20 years.
0.900

🆔 850ced92-c523-494b-8db8-dd7c0d20efa1

Simplified: Texas has harsh penalties for psilocybin possession.
Under federal law, simple possession of psilocybin is punishable by up to a year in jail and a minimum fine of $1,000.
0.900

🆔 6eda024f-b413-475a-901e-a2f45be5618d

Simplified: Federal law punishes psilocybin possession with jail and fines.
Possession with intent to distribute carries a penalty of up to 20 years in prison.
0.900

🆔 ef0756f3-c162-4eef-9345-787cab3d2b5b

Simplified: Federal law punishes intent to distribute with up to 20 years.